A Prospective, Single-Center, Randomized, Triple-Blinded, Placebo-Controlled Study of IL-1RA Treatment in Patients With Acute ACL Tear and Painful Effusions
Latest Information Update: 25 Nov 2021
At a glance
- Drugs Anakinra (Primary)
- Indications Ligament injuries; Osteoarthritis
- Focus Therapeutic Use
- Acronyms EASI ACL
- 23 Oct 2020 Status changed from recruiting to discontinued.
- 30 Mar 2020 Planned number of patients changed from 60 to 40.
- 26 Jun 2019 Planned End Date changed from 31 Dec 2021 to 1 Jun 2023.